CDX2 and esophageal cancer: Studies assessing CDX2 are mainly related to digestive tract tumors, and reveal an oncogenic role for CDX2 in esophageal cancer [7], but a suppressor function in colorectal [8], gastric [9], and breast [10] cancers.